| Matrix metalloproteinases (MMPs) and their specific tissue inhibitors (TIMPs) in mature human odontoblasts and pulp tissue | ||
|---|---|---|
| Prev | ||
Agnihotri R, Crawford HC, Haro H, Matrisian LM, Havrda MC & Liaw L (2001) Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J Biol Chem 276: 28261–7.
Ahrens D, Koch AE, Pope RM, Stein-Picarella M & Niedbala MJ (1996) Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 39: 1576–87.
Aimes RT & Quigley JP (1995) Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor- free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem 270: 5872–6.
Allan JA, Hembry RM, Angal S, Reynolds JJ & Murphy G (1991) Binding of latent and high Mr active forms of stromelysin to collagen is mediated by the C-terminal domain. J Cell Sci 99: 789–95.
Allan JA, Docherty AJ, Barker PJ, Huskisson NS, Reynolds JJ & Murphy G (1995) Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem J 309: 299–306.
van Amerongen JP, Lemmens IG & Tonino GJ (1983) The concentration, extractability and characterization of collagen in human dental pulp. Arch Oral Biol 28: 339–45.
Anglard P, Melot T, Guerin E, Thomas G & Basset P (1995) Structure and promoter characterization of the human stromelysin-3 gene. J Biol Chem 270: 20337–44.
Apte SS, Mattei MG & Olsen BR (1994) Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22. Genomics 19: 86–90.
Apte SS, Olsen BR & Murphy G (1995) The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem 270: 14313–8.
Arner EC, Decicco CP, Cherney R & Tortorella MD (1997) Cleavage of native cartilage aggrecan by neutrophil collagenase (MMP-8) is distinct from endogenous cleavage by aggrecanase. J Biol Chem 272: 9294–9.
Arza B, Hoylaerts MF, Felez J, Collen D & Lijnen HR (2000) Prostromelysin-1 (proMMP-3) stimulates plasminogen activation by tissue- type plasminogen activator. Eur J Biochem 267: 6378–84.
Atkinson SJ, Crabbe T, Cowell S, Ward RV, Butler MJ, Sato H, Seiki M, Reynolds JJ & Murphy G (1995) Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem 270: 30479-85.
Atkinson SJ, Patterson ML, Butler MJ & Murphy G (2001) Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type 1 collagen in a cell model. FEBS Lett 491: 222–6.
Bachmeier BE, Nerlich AG, Boukamp P, Lichtinghagen R, Tschesche H, Fritz H & Fink E (2000) Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1,-8, and -13 and of TIMP-1. Biol Chem 381: 509–16.
Bainton DF, Ullyot JL & Farquhar MG (1971) The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. J Exp Med 134: 907–34.
Bannikov GA, Karelina TV, Collier IE, Marmer BL & Goldberg GI (2002) Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide. J Biol Chem 277: 16022–7.
Baragi VM, Fliszar CJ, Conroy MC, Ye QZ, Shipley JM & Welgus HG (1994) Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin. J Biol Chem 269: 12692–7.
Bartlett JD, Simmer JP, Xue J, Margolis HC & Moreno EC (1996) Molecular cloning and mRNA tissue distribution of a novel matrix metalloproteinase isolated from porcine enamel organ. Gene 183: 123–8.
Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC & Chambon P (1990) A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699–704.
Becker J, Schuppan D, Benzian H, Bals T, Hahn EG, Cantaluppi C & Reichart P (1986) Immunohistochemical distribution of collagens types IV, V, and VI and of pro-collagens types I and III in human alveolar bone and dentin. J Histochem Cytochem 34: 1417–29.
Beier G & Engel J (1966) The renaturation of soluble collagen. Products formed at different temperatures. Biochemistry 5: 2744–55.
Belaaouaj A, Shipley JM, Kobayashi DK, Zimonjic DB, Popescu N, Silverman GA & Shapiro SD (1995) Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J Biol Chem 270: 14568–75.
Belaaouaj AA, Li A, Wun TC, Welgus HG & Shapiro SD (2000) Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. J Biol Chem 275: 27123–8.
Belkin AM, Akimov SS, Zaritskaya LS, Ratnikov BI, Deryugina EI & Strongin AY (2001) Matrix-dependent proteolysis of surface transglutaminase by membrane- type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem 276: 18415–22.
Benderdour M, Tardif G, Pelletier JP, Dupuis M, Geng C & Martel-Pelletier J (2002) A novel negative regulatory element in the human collagenase-3 proximal promoter region. Biochem Biophys Res Commun 291: 1151–9.
Berdal A, Balmain N, Thomasset M, Brehier A, Hotton D, Cuisinier-Gleizes P & Mathieu H (1989) Calbindins D-9kDa and -28kDa and enamel secretion in vitamin D- deficient and control rats. Connect Tissue Res 22: 165–71.
Bernardo MM, Brown S, Li ZH, Fridman R & Mobashery S (2002) Design, synthesis, and characterization of potent, slow-binding inhibitors that are selective for gelatinases. J Biol Chem 277: 11201–7.
Bessho K, Tanaka N, Matsumoto J, Tagawa T & Murata M (1991) Human dentin-matrix-derived bone morphogenetic protein. J Dent Res 70: 171–5.
Betti F & Katchburian E (1982) Proteolytic activity of developing dentin of rat tooth germs revealed by the gelatin-film substrate technique. Arch Oral Biol 27: 891–6.
Bian J & Sun Y (1997) Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol Cell Biol 17: 6330–8.
Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD & Overall CM (2001) Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Cancer Res 61: 3610–8.
Bini A, Itoh Y, Kudryk BJ & Nagase H (1996) Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): hydrolysis of the gamma Gly 404-Ala 405 peptide bond. Biochemistry 35: 13056–63.
Bishop MA & Yoshida S (1992) A permeability barrier to lanthanum and the presence of collagen between odontoblasts in pig molars. J Anat 181: 29–38.
Blavier L & Delaisse JM (1995) Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J Cell Sci 108: 3649–59.
Bode W, Fernandez-Catalan C, Tschesche H, Grams F, Nagase H & Maskos K (1999) Structural properties of matrix metalloproteinases. Cell Mol Life Sci 55: 639–52.
Bode W, Reinemer P, Huber R, Kleine T, Schnierer S & Tschesche H (1994) The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. Embo J 13: 1263–9.
Bolcato-Bellemin AL, Elkaim R, Abehsera A, Fausser JL, Haikel Y & Tenenbaum H (2000) Expression of mRNAs encoding for alpha and beta integrin subunits, MMPs, and TIMPs in stretched human periodontal ligament and gingival fibroblasts. J Dent Res 79: 1712–6.
Bond M, Fabunmi RP, Baker AH & Newby AC (1998) Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett 435: 29–34.
Bond M, Murphy G, Bennett MR, Amour A, Knauper V, Newby AC & Baker AH (2000) Localization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus. Metalloproteinase inhibition is associated with proapoptotic activity. J Biol Chem 275: 41358–63.
Boone TC, Johnson MJ, De Clerck YA & Langley KE (1990) cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc Natl Acad Sci U S A 87: 2800–4.
Bord S, Horner A, Beeton CA, Hembry RM & Compston JE (1999) Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) distribution in normal and pathological human bone. Bone 24: 229–35.
Borden P, Solymar D, Sucharczuk A, Lindman B, Cannon P & Heller RA (1996) Cytokine control of interstitial collagenase and collagenase-3 gene expression in human chondrocytes. J Biol Chem 271: 23577–81.
Boskey AL (1989) Noncollagenous matrix proteins and their role in mineralization. Bone Miner 6: 111–23.
Bourguignon LY, Gunja-Smith Z, Iida N, Zhu HB, Young LJ, Muller WJ & Cardiff RD (1998) CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol 176: 206–15.
von Bredow DC, Cress AE, Howard EW, Bowden GT & Nagle RB (1998) Activation of gelatinase-tissue-inhibitors-of-metalloproteinase complexes by matrilysin. Biochem J 331: 965–72.
Brown PD, Wakefield LM, Levinson AD & Sporn MB (1990) Physicochemical activation of recombinant latent transforming growth factor-beta"s 1, 2, and 3. Growth Factors 3: 35–43.
Bruner KL, Rodgers WH, Gold LI, Korc M, Hargrove JT, Matrisian LM & Osteen KG (1995) Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci U S A 92: 7362–6.
Burke JM, Balian G, Ross R & Bornstein (1977) Synthesis of types I and III procollagen and collagen by monkey aortic smooth muscle in vitro. Biochemistry 16: 3243–3249.
Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, Crabbe T, Clements J, d"Ortho MP & Murphy G (1998) The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 273: 871–80.
Butler GS, Apte SS, Willenbrock F & Murphy G (1999) Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions. J Biol Chem 274: 10846–51.
Butler WT, Munksgaard EC & Richardson WS, 3rd (1979) Dentin proteins: chemistry, structure and biosynthesis. J Dent Res 58: 817–24.
Buttice G, Quinones S & Kurkinen M (1991) The AP-1 site is required for basal expression but is not necessary for TPA-response of the human stromelysin gene. Nucleic Acids Res 19: 3723–31.
Buttice G & Kurkinen M (1993) A polyomavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13-acetate response of the human stromelysin gene. J Biol Chem 268: 7196–204.
Buttner FH, Chubinskaya S, Margerie D, Huch K, Flechtenmacher J, Cole AA, Kuettner KE & Bartnik E (1997) Expression of membrane type 1 matrix metalloproteinase in human articular cartilage. Arthritis Rheum 40: 704–9.
Calland JW, Harris SE & Carnes DL, Jr. (1997) Human pulp cells respond to calcitonin gene-related peptide in vitro. J Endod 23: 485–9.
Cao J, Hymowitz M, Conner C, Bahou WF & Zucker S (2000) The propeptide domain of membrane type 1-matrix metalloproteinase acts as an intramolecular chaperone when expressed in trans with the mature sequence in COS-1 cells. J Biol Chem 275: 29648–53.
Carmichael DF, Sommer A, Thompson RC, Anderson DC, Smith CG, Welgus HG & Stricklin GP (1986) Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci U S A 83: 2407–11.
Caron C, Xue J & Bartlett JD (1998) Expression and localization of membrane type 1 matrix metalloproteinase in tooth tissues. Matrix Biol 17: 501–11.
Cassidy N, Fahey M, Prime SS & Smith AJ (1997) Comparative analysis of transforming growth factor-beta isoforms 1-3 in human and rabbit dentin matrices. Arch Oral Biol 42: 219–23.
Ten Cate AR (1994a) Structure of oral tissues. In: Ten Cate AR (ed) Oral Histology. Development, Structure and Function. 4th edition. Mosby, St. Louis, pp. 45–57.
Ten Cate AR (1994b) Hard tissue formation and destruction. In: Ten Cate AR (ed) Oral Histology. Development, Structure and Function. 4th edition. Mosby. St. Louis, pp. 111–119.
Ten Cate AR (1994c) Dentinogenesis. In: Ten Cate AR (ed) Oral Histology. Development, Structure and Function. 4th edition. Mosby. St. Louis, pp. 147–168.
Caterina J, Shi J, Krakora S, Bartlett JD, Engler JA, Kozak CA & Birkedal-Hansen H (1999) Isolation, characterization, and chromosomal location of the mouse enamelysin gene. Genomics 62: 308–11.
Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA & Wozney JM (1990) Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci 87: 9843–7.
Celeste AJ, Ross JL, Yamali N & Wozney JM (1995) The molecular cloning of human bone morphogenetic proteins-10, -11, and -12, three new members of the transforming growth factor-beta superfamily. J Bone Miner Res 10: S336.
Centrella M, Horowitz MC, Wozney JM & McCarthy TL (1994) Transforming growth factor-beta gene family members and bone. Endocr Rev 15: 27–39.
Centrella M, Casinghino S, Kim J, Pham T, Rosen V, Wozney J & McCarthy TL (1995) Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype. Mol Cell Biol 15: 3273–81.
Chandler S, Cossins J, Lury J & Wells G (1996) Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem Biophys Res Commun 228: 421–9.
Chang YC, Mms, Yang SF & Hsieh YS (2001) Regulation of matrix metalloproteinase-2 production by cytokines and pharmacological agents in human pulp cell cultures. J Endod 27: 679–82.
Chung L, Shimokawa K, Dinakarpandian D, Grams F, Fields GB & Nagase H (2000) Identification of the (183)RWTNNFREY(191) region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity. J Biol Chem 275: 29610–7.
Clark IM, Rowan AD, Edwards DR, Bech-Hansen T, Mann DA, Bahr MJ & Cawston TE (1997) Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1. Biochem J 324: 611–7.
Cole AA, Chubinskaya S, Schumacher B, Huch K, Szabo G, Yao J, Mikecz K, Hasty KA & Kuettner KE (1996) Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. J Biol Chem 271: 11023–6.
Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He CS, Bauer EA & Goldberg GI (1988) H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 263: 6579–87.
Collier IE, Krasnov PA, Strongin AY, Birkedal-Hansen H & Goldberg GI (1992) Alanine scanning mutagenesis and functional analysis of the fibronectin- like collagen-binding domain from human 92-kDa type IV collagenase. J Biol Chem 267: 6776–81.
Conca W & Willmroth F (1994) Human T lymphocytes express a member of the Matrix Metalloproteinase gene family. Arthritis Rheum 37: 951–6.
Cossins J, Dudgeon TJ, Catlin G, Gearing AJ & Clements JM (1996) Identification of MMP-18, a putative novel human matrix metalloproteinase. Biochem Biophys Res Commun 228: 494–8.
Couve E (1986) Ultrastructural changes during the life cycle of human odontoblasts. Arch Oral Biol 31: 643–51.
Cox CF, White KC, Ramus DL, Farmer JB & Snuggs HM (1992) Reparative dentin: factors affecting its deposition. Quintessence Int 23: 257–70.
Crabbe T, O"Connell JP, Smith BJ & Docherty AJ (1994) Reciprocated matrix metalloproteinase activation: a process performed by interstitial collagenase and progelatinase A. Biochemistry 33: 14419–25.
Dai XF, Ten Cate AR & Limeback H (1991) The extent and distribution of intratubular collagen fibrils in human dentin. Arch Oral Biol 36: 775–8.
Dallas SL, Park-Snyder S, Miyazono K, Twardzik D, Mundy GR & Bonewald LF (1994) Characterization and autoregulation of latent transforming growth factor beta (TGF beta) complexes in osteoblast-like cell lines. Production of a latent complex lacking the latent TGF beta-binding protein. J Biol Chem 269: 6815–21.
Dallas SL, Miyazono K, Skerry TM, Mundy GR & Bonewald LF (1995) Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein. J Cell Biol 131: 539–49.
Damiens C, Fortun Y, Charrier C, Heymann D & Padrines M (2000) Modulation by soluble factors of gelatinase activities released by osteoblastic cells. Cytokine 12: 1727–31.
D"Angelo M, Billings PC, Pacifici M, Leboy PS & Kirsch T (2001) Authentic matrix vesicles contain active metalloproteases (MMP). a role for matrix vesicle-associated MMP-13 in activation of transforming growth factor-beta. J Biol Chem 276: 11347–53.
Davies G, Jiang WG & Mason MD (2001) Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin Cancer Res 7: 3289–97.
Davis GE (1991) Identification of an abundant latent 94-kDa gelatin-degrading metalloprotease in human saliva which is activated by acid exposure: implications for a role in digestion of collagenous proteins. Arch Biochem Biophys 286: 551–4.
Dayan D, Binderman I & Mechanic GL (1983) A preliminary study of activation of collagenase in carious human dentin matrix. Arch Oral Biol 28: 185–7.
De Clerck YA, Darville MI, Eeckhout Y & Rousseau GG (1994) Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2 (TIMP-2). Gene 139: 185–91.
De Coignac AB, Elson G, Delneste Y, Magistrelli G, Jeannin P, Aubry JP, Berthier O, Schmitt D, Bonnefoy JY & Gauchat JF (2000) Cloning of MMP-26. A novel matrilysin-like proteinase. Eur J Biochem 267: 3323–9.
Dean G, Young DA, Edwards DR & Clark IM (2000) The human tissue inhibitor of metalloproteinases (TIMP)-1 gene contains repressive elements within the promoter and intron 1. J Biol Chem 275: 32664–71.
Delany AM & Canalis E (2001) The metastasis-associated metalloproteinase stromelysin-3 is induced by transforming growth factor-beta in osteoblasts and fibroblasts. Endocrinology 142: 1561–6.
Demeule M, Brossard M, Page M, Gingras D & Beliveau R (2000) Matrix metalloproteinase inhibition by green tea catechins. Biochim Biophys Acta 1478: 51–60.
Den Besten PK, Punzi JS & Li W (1998) Purification and sequencing of a 21 kDa and 25 kDa bovine enamel metalloproteinase. Eur J Oral Sci 106 Suppl 1: 345–9.
Deryugina EI, Ratnikov B, Monosov E, Postnova TI, DiScipio R, Smith JW & Strongin AY (2001) MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res 263: 209–23.
Deryugina EI, Ratnikov BI, Postnova TI, Rozanov DV & Strongin AY (2002a) Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J Biol Chem 277: 9749–56.
Deryugina EI, Soroceanu L & Strongin AY (2002b) Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res 62: 580–8.
Desrochers PE, Jeffrey JJ & Weiss SJ (1991) Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity. J Clin Invest 87: 2258–65.
Djonov V, Hogger K, Sedlacek R, Laissue J & Draeger A (2001) MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours. J Pathol 195: 147–55.
Van Doren SR, Kurochkin AV, Ye QZ, Johnson LL, Hupe DJ & Zuiderweg ER (1993) Assignments for the main-chain nuclear magnetic resonances and delineation of the secondary structure of the catalytic domain of human stromelysin-1 as obtained from triple-resonance 3D NMR experiments. Biochemistry 32: 13109–22.
D"Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L & Murphy G (1997) Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 250: 751–7.
D"Souza R, Brown LR, Newland JR, Levy BM & Lachman LB (1989) Detection and characterization of interleukin-1 in human dental pulps. Arch Oral Biol 34: 307–13.
D"Souza RN, Bachman T, Baumgardner KR, Butler WT & Litz M (1995) Characterization of cellular responses involved in reparative dentinogenesis in rat molars. J Dent Res 74: 702–9.
Dube JL, Wang P, Elvin J, Lyons KM, Celeste AJ & Matzuk MM (1998) The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol 12: 1809–1817.
Duivenvoorden WC, Hirte HW & Singh G (1999) Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells. Clin Exp Metastasis 17: 27–34.
Dumas J, Hurion N, Weill R & Keil B (1985) Collagenase in mineralized tissues of human teeth. FEBS Lett 187: 51–5.
Dung SZ, Gregory RL, Li Y & Stookey GK (1995) Effect of lactic acid and proteolytic enzymes on the release of organic matrix components from human root dentin. Caries Res 29: 483–9.
Edwards DR, Leco KJ, Beaudry PP, Atadja PW, Veillette C & Riabowol KT (1996) Differential effects of transforming growth factor-beta 1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts. Exp Gerontol 31: 207–23.
Egeblad M & Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161–74.
Ellerbroek SM, Wu YI & Stack MS (2001) Type I collagen stabilization of matrix metalloproteinase-2. Arch Biochem Biophys 390: 51–6.
Embery G, Rees S, Hall R, Rose K, Waddington R & Shellis P (1998) Calcium- and hydroxyapatite-binding properties of glucuronic acid-rich and iduronic acid-rich glycosaminoglycans and proteoglycans. Eur J Oral Sci 106 Suppl 1: 267–73.
Embery G, Hall R, Waddington R, Septier D & Goldberg M (2001) Proteoglycans in dentinogenesis. Crit Rev Oral Biol Med 12: 331–49.
English WR, Puente XS, Freije JM, Knauper V, Amour A, Merryweather A, Lopez-Otin C & Murphy G (2000) Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2. J Biol Chem 275: 14046–55.
English WR, Velasco G, Stracke JO, Knäuper V & Murphy G (2001) Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25). FEBS Lett 491: 137–42.
Feinberg MW, Jain MK, Werner F, Sibinga NE, Wiesel P, Wang H, Topper JN, Perrella MA & Lee ME (2000) Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages. J Biol Chem 275: 25766–73.
Fernandez-Catalan C, Bode W, Huber R, Turk D, Calvete JJ, Lichte A, Tschesche H & Maskos K (1998) Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. Embo J 17: 5238–48.
Festuccia C, Angelucci A, Gravina GL, Villanova I, Teti A, Albini A, Bologna M & Abini A (2000) Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells. Int J Cancer 85: 407–15.
Fields GB, Van Wart HE & Birkedal-Hansen H (1987) Sequence specificity of human skin fibroblast collagenase. Evidence for the role of collagen structure in determining the collagenase cleavage site. J Biol Chem 262: 6221–6.
Fields GB, Netzel-Arnett SJ, Windsor LJ, Engler JA, Birkedal-Hansen H & Van Wart HE (1990) Proteolytic activities of human fibroblast collagenase: hydrolysis of a broad range of substrates at a single active site. Biochemistry 29: 6670–7.
Finkelman RD, Mohan S, Jennings JC, Taylor AK, Jepsen S & Baylink DJ (1990) Quantitation of growth factors IGF-I, SGF/IGF-II, and TGF-beta in human dentin. J Bone Miner Res 5: 717–23.
Flannery CR, Lark MW & Sandy JD (1992) Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage. J Biol Chem 267: 1008–14.
Fosang AJ, Neame PJ, Hardingham TE, Murphy G & Hamilton JA (1991) Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins. J Biol Chem 266: 15579–82.
Fosang AJ, Neame PJ, Last K, Hardingham TE, Murphy G & Hamilton JA (1992) The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J Biol Chem 267: 19470–4.
Fosang AJ, Last K, Knauper V, Murphy G & Neame PJ (1996) Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 380: 17–20.
Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J & Lopez-Otin C (1994) Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269: 16766–73.
Freimark BD, Feeser WS & Rosenfeld SA (1994) Multiple sites of the propeptide region of human stromelysin-1 are required for maintaining a latent form of the enzyme. J Biol Chem 269: 26982–7.
Fridman R, Toth M, Pena D & Mobashery S (1995) Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res 55: 2548–55.
Fromigue O, Marie PJ & Lomri A (1998) Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation. J Cell Biochem 68: 411–26.
Fukae M, Kaneko I, Tanabe T & Shimizu M (1991) Metalloproteinases in the mineralized compartments of porcine dentin as detected by substrate-gel electrophoresis. Arch Oral Biol 36: 567–73.
Fukae M, Tanabe T, Uchida T, Lee SK, Ryu OH, Murakami C, Wakida K, Simmer JP, Yamada Y & Bartlett JD (1998) Enamelysin (matrix metalloproteinase-20): localization in the developing tooth and effects of pH and calcium on amelogenin hydrolysis. J Dent Res 77: 1580–8.
Fukui N, McAlinden A, Zhu Y, Crouch E, Broekelmann TJ, Mecham RP & Sandell LJ (2002) Processing of type II procollagen amino propeptide by matrix metalloproteinases. J Biol Chem 277: 2193–201.
Gadher SJ, Schmid TM, Heck LW & Woolley DE (1989) Cleavage of collagen type X by human synovial collagenase and neutrophil elastase. Matrix 9: 109–15.
Gage JP (1984) Electrophoretic characterization of peptides from normal mature human dentin. Arch Oral Biol 29: 575–80.
Gaire M, Magbanua Z, McDonnell S, McNeil L, Lovett DH & Matrisian LM (1994) Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J Biol Chem 269: 2032–40.
Gall AL, Ruff M, Kannan R, Cuniasse P, Yiotakis A, Dive V, Rio MC, Basset P & Moras D (2001) Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state. J Mol Biol 307: 577–86.
Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL et al. (1994) Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 370: 555–7.
Gearing AJ, Thorpe SJ, Miller K, Mangan M, Varley PG, Dudgeon T, Ward G, Turner C & Thorpe R (2002) Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysin. Immunol Lett 81: 41–8.
Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG & Quaranta V (1997) Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277: 225–8.
Gingras D, Bousquet-Gagnon N, Langlois S, Lachambre MP, Annabi B & Beliveau R (2001) Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett 507: 231–6.
Goldberg GI, Strongin A, Collier IE, Genrich LT & Marmer BL (1992) Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 267: 4583–91.
Gomez DE, Alonso DF, Yoshiji H & Thorgeirsson UP (1997) Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 74: 111–22.
Gomis-Ruth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, Yoshida N, Nagase H, Brew K, Bourenkov GP, Bartunik H & Bode W (1997) Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389: 77–81.
Granström G (1984) Further evidence of an intravesicular Ca2+- pump in odontoblasts from rat incisors. Arch Oral Biol 29: 599–606.
Granström G & Linde A (1981) ATP-dependent uptake of Ca2+ by a microsomal fraction from rat incisor odontoblasts. Calcif Tissue Int 33: 125–8.
Grant GA, Eisen AZ, Marmer BL, Roswit WT & Goldberg GI (1987) The activation of human skin fibroblast procollagenase. Sequence identification of the major conversion products. J Biol Chem 262: 5886–9.
Greene J, Wang M, Liu YE, Raymond LA, Rosen C & Shi YE (1996) Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem 271: 30375–80.
Gu K, Chang S, Ritchie HH, Clarkson BH & Rutherford RB (2000) Molecular cloning of a human dentin sialophosphoprotein gene. Eur J Oral Sci 108: 35–42.
Gu K, Smoke RH & Rutherford RB (1996) Expression of genes for bone morphogenetic proteins and receptors in human dental pulp. Arch Oral Biol 41: 919–23.
Guerin E, Ludwig MG, Basset P & Anglard P (1997) Stromelysin-3 induction and interstitial collagenase repression by retinoic acid. Therapeutical implication of receptor-selective retinoids dissociating transactivation and AP-1-mediated transrepression. J Biol Chem 272: 11088–95.
Gunja-Smith Z, Nagase H & Woessner JF, Jr. (1989) Purification of the neutral proteoglycan-degrading metalloproteinase from human articular cartilage tissue and its identification as stromelysin matrix metalloproteinase-3. Biochem J 258: 115–9.
Gururajan R, Grenet J, Lahti JM & Kidd VJ (1998a) Isolation and characterization of two novel metalloproteinase genes linked to the Cdc2L locus on human chromosome 1p36.3. Genomics 52: 101–6.
Gururajan R, Lahti JM, Grenet J, Easton J, Gruber I, Ambros PF & Kidd VJ (1998b) Duplication of a genomic region containing the Cdc2L1-2 and MMP21-22 genes on human chromosome 1p36.3 and their linkage to D1Z2. Genome Res 8: 929–39.
Hall R, Septier D, Embery G & Goldberg M (1999) Stromelysin-1 (MMP-3) in forming enamel and predentin in rat incisor-coordinated distribution with proteoglycans suggests a functional role. Histochem J 31: 761–70.
Hammani K, Blakis A, Morsette D, Bowcock AM, Schmutte C, Henriet P & DeClerck YA (1996) Structure and characterization of the human tissue inhibitor of metalloproteinases-2 gene. J Biol Chem 271: 25498–505.
Hanemaaijer R, Sorsa T, Konttinen YT, Ding Y, Sutinen M, Visser H, van Hinsbergh VW, Helaakoski T, Kainulainen T, Ronka H, Tschesche H & Salo T (1997) Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor- alpha and doxycycline. J Biol Chem 272: 31504–9.
Harrington WF & Karr GM (1970) Collagen structure in solution. II. Analysis of refolding kinetics in terms of nucleation and growth processes. Biochemistry 9: 3725–33.
Harris SE, Bonewald LF, Harris MA, Sabatini M, Dallas S, Feng JQ, Ghosh-Choudhury N, Wozney J & Mundy GR (1994) Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 9: 855–63.
Hasty KA, Hibbs MS, Kang AH & Mainardi CL (1986) Secreted forms of human neutrophil collagenase. J Biol Chem 261: 5645–50.
Hasty KA, Jeffrey JJ, Hibbs MS & Welgus HG (1987) The collagen substrate specificity of human neutrophil collagenase. J Biol Chem 262: 10048–52.
Hasty KA, Pourmotabbed TF, Goldberg GI, Thompson JP, Spinella DG, Stevens RM & Mainardi CL (1990) Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J Biol Chem 265: 11421–4.
Hayakawa T, Yamashita K, Tanzawa K, Uchijima E & Iwata K (1992) Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 298: 29–32.
He CS, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ & Goldberg GI (1989) Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci U S A 86: 2632–6.
Heikinheimo K (1994) Stage-specific expression of decapentaplegic-Vg-related genes 2, 4, and 6 (bone morphogenetic proteins 2, 4, and 6) during human tooth morphogenesis. J Dent Res 73: 590–7.
Heikinheimo K & Salo T (1995) Expression of basement membrane type IV collagen and type IV collagenases (MMP-2 and MMP-9) in human fetal teeth. J Dent Res 74: 1226–34.
Hembry RM, Bagga MR, Reynolds JJ & Hamblen DL (1995) Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 54: 25–32.
Herman MP, Sukhova GK, Kisiel W, Foster D, Kehry MR, Libby P & Schonbeck U (2001) Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J Clin Invest 107: 1117–26.
Hernandez-Barrantes S, Shimura Y, Soloway PD, Sang QA & Fridman R (2001) Differential roles of TIMP-4 and TIMP-2 in pro-MMP-2 activation by MT1-MMP. Biochem Biophys Res Commun 281: 126–30.
Hiller O, Lichte A, Oberpichler A, Kocourek A & Tschesche H (2000) Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. J Biol Chem 275: 33008–13.
Himelstein BP, Lee EJ, Sato H, Seiki M & Muschel RJ (1998) Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat. Clin Exp Metastasis 16: 169–77.
Hipps DS, Hembry RM, Docherty AJ, Reynolds JJ & Murphy G (1991) Purification and characterization of human 72-kDa gelatinase (type IV collagenase). Use of immunolocalisation to demonstrate the non-coordinate regulation of the 72-kDa and 95-kDa gelatinases by human fibroblasts. Biol Chem Hoppe Seyler 372: 287–96.
Hoodless PA, Haerry T, Abdollah S, Stapleton M, O"Connor MB, Attisano L & Wrana JL (1996) MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85: 489–500.
Hoshino T, Kishi J, Kawai T, Kobayashi K & Hayakawa T (1986) Immunoelectron microscopic localization of collagenase inhibitor in bovine dentin. Coll Relat Res 6: 303–12.
Howard EW, Bullen EC & Banda MJ (1991) Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem 266: 13070–5.
Hu SI, Klein M, Carozza M, Rediske J, Peppard J & Qi JS (1999) Identification of a splice variant of neutrophil collagenase (MMP-8). FEBS Lett 443: 8–10.
Huang GT, Potente AP, Kim JW, Chugal N & Zhang X (1999) Increased interleukin-8 expression in inflamed human dental pulps. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88: 214–20.
Huang W, Li WQ, Dehnade F & Zafarullah M (2002) Tissue inhibitor of metalloproteinases-4 (TIMP-4) gene expression is increased in human osteoarthritic femoral head cartilage. J Cell Biochem 85: 295–303.
Huhtala P, Chow LT & Tryggvason K (1990) Structure of the human type IV collagenase gene. J Biol Chem 265: 11077–82.
Huhtala P, Tuuttila A, Chow LT, Lohi J, Keski-Oja J & Tryggvason K (1991) Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J Biol Chem 266: 16485–90.
Hui W, Rowan AD & Cawston T (2000) Transforming growth factor beta1 blocks the release of collagen fragments from boving nasal cartilage stimulated by oncostatin M in combination with IL-1alpha. Cytokine 12: 765–9.
Ibbotson KJ, Orcutt CM, Anglin AM & D"Souza SM (1989) Effects of transforming growth factors beta 1 and beta 2 on a mouse clonal, osteoblastlike cell line MC3T3-E1. J Bone Miner Res 4: 37–45.
Ihn H, Yamane K, Asano Y, Kubo M & Tamaki K (2002) IL-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase dependent pathway. J Immunol 168: 1895–902.
Illman SA, Keski-Oja J & Lohi J (2001) Promoter characterization of the human and mouse epilysin (MMP-28) genes. Gene 275: 185–94.
Imai K, Kusakabe M, Sakakura T, Nakanishi I & Okada Y (1994) Susceptibility of tenascin to degradation by matrix metalloproteinases and serine proteinases. FEBS Lett 352: 216–8.
Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M & Okada Y (1996) Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res 56: 2707–10.
Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD & Okada Y (1997) Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J 322: 809–14.
Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M & Miyazono K (1997) Smad6 inhibits signalling by the TGF-beta superfamily. Nature 389: 622–6.
Inage T & Toda Y (1996) Gene expression of TGF-beta 1 and elaboration of extracellular matrix using in situ hybridization and EM radioautography during dentinogenesis. Anat Rec 245: 250–66.
Ingman T, Sorsa T, Lindy O, Koski H & Konttinen YT (1994) Multiple forms of gelatinases/type IV collagenases in saliva and gingival crevicular fluid of periodontitis patients. J Clin Periodontol 21: 26–31.
Ishiguro K, Yamashita K, Nakagaki H, Iwata K & Hayakawa T (1994) Identification of tissue inhibitor of metalloproteinases-1 (TIMP-1) in human teeth and its distribution in cementum and dentin. Arch Oral Biol 39: 345–9.
Ito A & Nagase H (1988) Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase. Arch Biochem Biophys 267: 211–6.
Ito A, Mukaiyama A, Itoh Y, Nagase H, Thogersen IB, Enghild JJ, Sasaguri Y & Mori Y (1996) Degradation of interleukin 1beta by matrix metalloproteinases. J Biol Chem 271: 14657–60.
Itoh Y & Nagase H (1995) Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J Biol Chem 270: 16518–21.
Itoh Y, Kajita M, Kinoh H, Mori H, Okada A & Seiki M (1999) Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase. J Biol Chem 274: 34260–6.
Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T & Seiki M (2001) Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. Embo J 20: 4782–93.
James JA, Irwin CR & Linden GJ (1998) Gingival fibroblast response to cyclosporin A and transforming growth factor beta 1. J Periodontal Res 33: 40–8.
Jimenez MJ, Balbin M, Lopez JM, Alvarez J, Komori T & Lopez-Otin C (1999) Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol Cell Biol 19: 4431–42.
Jo Y, Yeon J, Kim HJ & Lee ST (2000) Analysis of tissue inhibitor of metalloproteinases-2 effect on pro- matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. Biochem J 345 Pt 3: 511–9.
Johansson N, Saarialho-Kere U, Airola K, Herva R, Nissinen L, Westermarck J, Vuorio E, Heino J & Kahari VM (1997) Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn 208: 387–97.
Jones SJ & Boyde A (1984) Ultrastructure of dentin and dentinogenesis. In: Linde A (ed) Dentin and Dentinogenesis. Vol 1. CRC Press, Boca Raton, p 81–134.
Jontell M & Linde A (1983) Non-collagenous proteins of predentin from dentinogenically active bovine teeth. Biochem J. 769–76.
Kajita M, Kinoh H, Ito N, Takamura A, Itoh Y, Okada A, Sato H & Seiki M (1999) Human membrane type-4 matrix metalloproteinase (MT4-MMP) is encoded by a novel major transcript: isolation of complementary DNA clones for human and mouse mt4-mmp transcripts. FEBS Lett 457: 353–6.
Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H & Seiki M (2001) Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153: 893–904.
Kang T, Nagase H & Pei D (2002) Activation of membrane-type matrix metalloproteinase 3 zymogen by the proprotein convertase furin in the trans-Golgi network. Cancer Res 62: 675–81.
Kang T, Yi J, Guo A, Wang X, Overall CM, Jiang W, Elde R, Borregaard N & Pei D (2001) Subcellular distribution and cytokine- and chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in neutrophils. J Biol Chem 276: 21960–8.
Karjalainen S & Söderling E (1984) Dentino-pulpal collagen and the incorporation of 3H-proline by sound and carious human teeth in vitro. J Buccale 12: 309–16.
Karjalainen S, Söderling E, Pelliniemi L & Foidart JM (1986) Immunohistochemical localization of types I and III collagen and fibronectin in the dentin of carious human teeth. Arch Oral Biol 31: 801–6.
Kerkelä E, Bohling T, Herva R, Uria JA & Saarialho-Kere U (2001) Human macrophage metalloelastase (MMP-12) expression is induced in chondrocytes during fetal development and malignant transformation. Bone 29: 487–93.
Kerr LD, Holt JT & Matrisian LM (1988) Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science 242: 1424–7.
Kerr LD, Miller DB & Matrisian LM (1990) TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 61: 267–78.
Kielty CM, Hopkinson I & Grant ME (1993) Collagen: The collagen family: Structure, assembly and organization in the extracellular matrix. In: Royce PM & Steinmann B (eds) Connective Tissue and Its Heritable Disordes. Molecular, Genetics, and Medical Aspects. Wiley-Liss, Inc., New York, p 103–147.
Kinney JH, Balooch M, Marshall GW & Marshall SJ (1999) A micromechanics model of the elastic properties of human dentin. Arch Oral Biol 44: 813–22.
Kinoshita T, Sato H, Okada A, Ohuchi E, Imai K, Okada Y & Seiki M (1998) TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem 273: 16098–103.
Kiyama R, Tamura Y, Watanabe F, Tsuzuki H, Ohtani M & Yodo M (1999) Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors. J Med Chem 42: 1723–38.
Knäuper V, Wilhelm SM, Seperack PK, DeClerck YA, Langley KE, Osthues A & Tschesche H (1993) Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem J 295: 581–6.
Knäuper V, Lopez-Otin C, Smith B, Knight G & Murphy G (1996a) Biochemical characterization of human collagenase-3. J Biol Chem 271: 1544–50.
Knäuper V, Murphy G & Tschesche H (1996b) Activation of human neutrophil procollagenase by stromelysin 2. Eur J Biochem 235: 187–91.
Knäuper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, Hembry RM & Murphy G (1996c) Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 271: 17124–31.
Knäuper V, Cowell S, Smith B, Lopez-Otin C, O"Shea M, Morris H, Zardi L & Murphy G (1997) The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 272: 7608–16.
Kojima S, Itoh Y, Matsumoto S, Masuho Y & Seiki M (2000) Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP. FEBS Lett 480: 142–6.
Kolb C, Mauch S, Peter HH, Krawinkel U & Sedlacek R (1997) The matrix metalloproteinase RASI-1 is expressed in synovial blood vessels of a rheumatoid arthritis patient. Immunol Lett 57: 83–8.
Kolb C, Mauch S, Krawinkel U & Sedlacek R (1999) Matrix metalloproteinase-19 in capillary endothelial cells: expression in acutely, but not in chronically, inflamed synovium. Exp Cell Res 250: 122–30.
Kolkenbrock H, Hecker-Kia A, Orgel D, Kinawi A & Ulbrich N (1996) Progelatinase B forms from human neutrophils. complex formation of monomer/lipocalin with TIMP-1. Biol Chem 377: 529–33.
Kolkenbrock H, Essers L, Ulbrich N & Will H (1999) Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase. Biol Chem 380: 1103–8.
Koolwijk P, Sidenius N, Peters E, Sier CF, Hanemaaijer R, Blasi F & van Hinsbergh VW (2001) Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices. Blood 97: 3123–31.
Kremer EA, Chen Y, Suzuki K, Nagase H & Gorski JP (1998) Hydroxyapatite induces autolytic degradation and inactivation of matrix metalloproteinase-1 and -3. J Bone Miner Res 13: 1890–902.
Lang R, Kocourek A, Braun M, Tschesche H, Huber R, Bode W & Maskos K (2001) Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure. J Mol Biol 312: 731–42.
Langton KP, Barker MD & McKie N (1998) Localization of the functional domains of human tissue inhibitor of metalloproteinases-3 and the effects of a Sorsby"s fundus dystrophy mutation. J Biol Chem 273: 16778–81.
Larmas M (2001) Odontoblast function seen as the response of dentinal tissue to dental caries. Adv Dent Res 15: 68–71.
Lehti K, Lohi J, Juntunen MM, Pei D & Keski-Oja J (2002) Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase. J Biol Chem 277: 8440–8.
Lesot H, Begue-Kirn C, Kubler MD, Meyer JM, Smith AJ, Cassidy N & Ruch JV (1993) Experimental induction of odontoblast differentiation and stimulation during reparative process. Cells Materials 3: 201–207.
Levin LG, Rudd A, Bletsa A & Reisner H (1999) Expression of IL-8 by cells of the odontoblast layer in vitro. Eur J Oral Sci 107: 131–7.
Li J, Brick P, O"Hare MC, Skarzynski T, Lloyd LF, Curry VA, Clark IM, Bigg HF, Hazleman BL, Cawston TE et al. (1995) Structure of full-length porcine synovial collagenase reveals a C- terminal domain containing a calcium-linked, four-bladed beta-propeller. Structure 3: 541–9.
Li W, Machule D, Gao C & DenBesten PK (1999) Activation of recombinant bovine matrix metalloproteinase-20 and its hydrolysis of two amelogenin oligopeptides. Eur J Oral Sci 107: 352–9.
Lijnen HR, Arza B, Van Hoef B, Collen D & Declerck PJ (2000) Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3). J Biol Chem 275: 37645–50.
Lijnen HR, Van Hoef B & Collen D (2001) Inactivation of the serpin alpha(2)-antiplasmin by stromelysin-1. Biochim Biophys Acta 1547: 206–13.
Lin HC, Chang JH, Jain S, Gabison EE, Kure T, Kato T, Fukai N & Azar DT (2001) Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment. Invest Ophthalmol Vis Sci 42: 2517–24.
Lin SK, Wang CC, Huang S, Lee JJ, Chiang CP, Lan WH & Hong CY (2001) Induction of dental pulp fibroblast matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expression by interleukin- 1alpha and tumor necrosis factor-alpha through a prostaglandin- dependent pathway. J Endod 27: 185–9.
Lindy O, Konttinen YT, Sorsa T, Ding Y, Santavirta S, Ceponis A & Lopez-Otin C (1997) Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum 40: 1391–9.
Liotta LA, Tryggvason K, Garbisa S, Robey PG & Abe S (1981) Partial purification and characterization of a neutral protease which cleaves type IV collagen. Biochemistry 20: 100–4.
Liu F, Ventura F, Doody J & Massague J (1995) Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol Cell Biol 15: 3479–86.
Llano E, Pendas AM, Knauper V, Sorsa T, Salo T, Salido E, Murphy G, Simmer JP, Bartlett JD & Lopez-Otin C (1997) Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry 36: 15101–8.
Llano E, Pendas AM, Freije JP, Nakano A, Knäuper V, Murphy G & Lopez-Otin C (1999) Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors. Cancer Res 59: 2570–6.
Lopez-Otin C & Overall CM (2002) Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol 3: 509–19.
Lohi J, Lehti K, Westermarck J, Kahari VM & Keski-Oja J (1996) Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem 239: 239–47.
Lohi J, Lehti K, Valtanen H, Parks WC & Keski-Oja J (2000) Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene. Gene 242: 75–86.
Lohi J, Wilson CL, Roby JD & Parks WC (2001) Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J Biol Chem 276: 10134–44.
Lovejoy B, Cleasby A, Hassell AM, Longley K, Luther MA, Weigl D, McGeehan G, McElroy AB, Drewry D, Lambert MH & et al. (1994) Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor. Science 263: 375–7.
Lukinmaa PL & Waltimo J (1992) Immunohistochemical localization of types I, V, and VI collagen in human permanent teeth and periodontal ligament. J Dent Res 71: 391–7.
Lukinmaa PL, Vaahtokari A, Vainio S & Thesleff I (1992) Expression of type I collagen pro-alpha 2 chain mRNA in adult human permanent teeth as revealed by in situ hybridization. J Dent Res 71: 36–42.
Lukinmaa PL, Vaahtokari A, Vainio S, Sandberg M, Waltimo J & Thesleff I (1993) Transient expression of type III collagen by odontoblasts: developmental changes in the distribution of pro-alpha 1(III) and pro-alpha 1(I) collagen mRNAs in dental tissues. Matrix 13: 503–15.
Lundgren T & Linde A (1988) Na+/Ca2+ antiports in membranes of rat incisor odontoblasts. J Oral Pathol 17: 560–3.
Luo D, Guerin E, Ludwig MG, Stoll I, Basset P & Anglard P (1999) Transcriptional induction of stromelysin-3 in mesodermal cells is mediated by an upstream CCAAT/enhancer-binding protein element associated with a DNase I-hypersensitive site. J Biol Chem 274: 37177–85.
Luo XH & Liao EY (2001) Progesterone differentially regulates the membrane-type matrix metalloproteinase-1 (MT1-MMP) compartment of proMMP-2 activation in MG-63 cells. Horm Metab Res 33: 383–8.
Madlener M, Mauch C, Conca W, Brauchle M, Parks WC & Werner S (1996) Regulation of the expression of stromelysin-2 by growth factors in keratinocytes: implications for normal and impaired wound healing. Biochem J 320: 659–64.
Maeda S, Dean DD, Gomez R, Schwartz Z & Boyan BD (2002) The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3). Calcif Tissue Int 70: 54–65.
Magloire H, Joffre A, Azerad J & Lawson DE (1988a) Localization of 28 kDa calbindin in human odontoblasts. Cell Tissue Res 254: 341–6.
Magloire H, Joffre A & Hartmann DJ (1988b) Localization and synthesis of type III collagen and fibronectin in human reparative dentin. Immunoperoxidase and immunogold staining. Histochemistry 88: 141–9.
Magloire H, Bouvier M & Joffre A (1992) Odontoblast response under carious lesions. Proc Finn Dent Soc 88: 257–74.
Mainardi CL, Pourmotabbed TF & Hasty KA (1991) Inflammatory phagocytes and connective tissue degrading metalloproteinases. Am J Med Sci 302: 171–5.
Manes S, Mira E, Barbacid MM, Cipres A, Fernandez-Resa P, Buesa JM, Merida I, Aracil M, Marquez G & Martinez AC (1997) Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J Biol Chem 272: 25706–12.
Marchenko GN, Ratnikov BI, Rozanov DV, Godzik A, Deryugina EI & Strongin AY (2001) Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin. Biochem J 356: 705–18.
Marchenko GN & Strongin AY (2001) MMP-28, a new human matrix metalloproteinase with an unusual cysteine-switch sequence is widely expressed in tumors. Gene 265: 87–93.
Marchenko ND, Marchenko GN & Strongin AY (2002) Unconventional activation mechanisms of MMP-26, a human matrix metalloproteinase with a unique PHCGXXD cysteine-switch motif. J Biol Chem 277: 18967–72.
Martin-De Las Heras S, Valenzuela A & Overall CM (2000) The matrix metalloproteinase gelatinase A in human dentin. Arch Oral Biol 45: 757–65.
Matsumoto S, Katoh M, Saito S, Watanabe T & Masuho Y (1997) Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA. Biochim Biophys Acta 1354: 159–70.
Matsushima K, Ohbayashi E, Takeuchi H, Hosoya S, Abiko Y & Yamazaki M (1998) Stimulation of interleukin-6 production in human dental pulp cells by peptidoglycans from Lactobacillus casei. J Endod 24: 252–5.
Matsushita K, Motani R, Sakuta T, Nagaoka S, Matsuyama T, Abeyama K, Maruyama I, Takada H & Torii M (1999) Lipopolysaccharide enhances the production of vascular endothelial growth factor by human pulp cells in culture. Infect Immun 67: 1633–9.
Mauch S, Kolb C, Kolb B, Sadowski T & Sedlacek R (2002) Matrix metalloproteinase-19 is expressed in myeloid cells in an adhesion-dependent manner and associates with the cell surface. J Immunol 168: 1244–51.
Meikle MC, Bord S, Hembry RM, Compston J, Croucher PI, Reynolds JJ (1992) Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines. J Cell Sci 103 (Pt 4): 1093–1099.
Melin M, Joffre-Romeas A, Farges JC, Couble ML, Magloire H & Bleicher F (2000) Effects of TGFbeta1 on dental pulp cells in cultured human tooth slices. J Dent Res 79: 1689–96.
Melkko J, Kauppila S, Niemi S, Risteli L, Haukipuro K, Jukkola A & Risteli J (1996) Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem 42: 947–54.
Mertens PR, Alfonso-Jaume MA, Steinmann K & Lovett DH (1998) A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription. J Biol Chem 273: 32957–65.
Michaelis J, Vissers MC & Winterbourn CC (1990) Human neutrophil collagenase cleaves alpha 1-antitrypsin. Biochem J 270: 809–14.
Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KF & Hambor JE (1996) Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 97: 761–8.
Mix KS, Mengshol JA, Benbow U, Vincenti MP, Sporn MB & Brinckerhoff CE (2001) A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines. Arthritis Rheum 44: 1096–104.
Miyazaki K, Hattori Y, Umenishi F, Yasumitsu H & Umeda M (1990) Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line. Cancer Res 50: 7758–64.
Mizutani A, Sugiyama I, Kuno E, Matsunaga S & Tsukagoshi N (2001) Expression of matrix metalloproteinases during ascorbate-induced differentiation of osteoblastic MC3T3-E1 cells. J Bone Miner Res 16: 2043–9.
Moilanen M, Pirila E, Grenman R, Sorsa T & Salo T (2002) Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinomas. J Pathol 197: 72–81.
Morgunova E, Tuuttila A, Bergmann U, Isupov M, Lindqvist Y, Schneider G & Tryggvason K (1999) Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. Science 284: 1667–70.
Morrison CJ, Butler GS, Bigg HF, Roberts CR, Soloway PD & Overall CM (2001) Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway. J Biol Chem 276: 47402–10.
Moule AJ, Li H & Bartold PM (1995) Donor variability in the proliferation of human dental pulp fibroblasts. Aust Dent J 40: 110–4.
Moy FJ, Chanda PK, Chen JM, Cosmi S, Edris W, Levin JI & Powers R (2000) High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor. J Mol Biol 302: 671–89.
Muller D, Quantin B, Gesnel MC, Millon-Collard R, Abecassis J & Breathnach R (1988) The collagenase gene family in humans consists of at least four members. Biochem J 253: 187–92.
Munksgaard ED, Rhodes M, Mayne R & Butler WT (1978) Collagen synthesis and secretion by rat incisor odontoblasts in organ culture. Eur J Biochem 82: 609–17.
Munksgaard EC & Moe D (1980) Types of collagen in an extract of odontoblasts and dentin from developing bovine teeth. Arch Oral Biol 25: 485–89.
Murphy G, Hembry RM, McGarrity AM, Reynolds JJ & Henderson B (1989) Gelatinase (type IV collagenase) immunolocalization in cells and tissues: use of an antiserum to rabbit bone gelatinase that identifies high and low Mr forms. J Cell Sci 92: 487–95.
Murphy G, Cockett MI, Ward RV & Docherty AJ (1991) Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J 277: 277–9.
Murphy G, Nguyen Q, Cockett MI, Atkinson SJ, Allan JA, Knight CG, Willenbrock F & Docherty AJ (1994) Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J Biol Chem 269: 6632–6.
Nagase H, Suzuki K, Morodomi T, Enghild JJ & Salvesen G (1992) Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3. Matrix Suppl 1: 237–44.
Nakada M, Yamada A, Takino T, Miyamori H, Takahashi T, Yamashita J & Sato H (2001) Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes. Cancer Res 61: 8896–902.
Nakamura H, Fujii Y, Ohuchi E, Yamamoto E & Okada Y (1998) Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases. Eur J Biochem 253: 67–75.
Nakano A, Tani E, Miyazaki K, Furuyama J & Matsumoto T (1993) Expressions of matrilysin and stromelysin in human glioma cells. Biochem Biophys Res Commun 192: 999–1003.
Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH & ten Dijke P (1997a) Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389: 631–5.
Nakao A, Imamura T, Souchelnytskyi S, Kawabata M, Ishisaki A, Oeda E, Tamaki K, Hanai J, Heldin CH, Miyazono K & ten Dijke P (1997b) TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. Embo J 16: 5353–62.
Nakashima M (1992) The effects of growth factors on DNA synthesis, proteoglycan synthesis and alkaline phosphatase activity in bovine dental pulp cells. Arch Oral Biol 37: 231–6.
Nakashima M (1994) Induction of dentin formation on canine amputated pulp by recombinant human bone morphogenetic proteins (BMP)-2 and -4. J Dent Res 73: 1515–22.
Nemeth JA, Rafe A, Steiner M & Goolsby CL (1996) TIMP-2 growth-stimulatory activity: a concentration- and cell type- specific response in the presence of insulin. Exp Cell Res 224: 110–5.
Nguyen M, Arkell J & Jackson CJ (2000) Activated protein C directly activates human endothelial gelatinase A. J Biol Chem 275: 9095–8.
Nguyen Q, Willenbrock F, Cockett MI, O"Shea M, Docherty AJ & Murphy G (1994) Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A. Biochemistry 33: 2089–95.
Nicholson R, Murphy G & Breathnach R (1989) Human and rat malignant-tumor-associated mRNAs encode stromelysin-like metalloproteinases. Biochemistry 28: 5195–203.
Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM & Mareel M (2001) Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 114: 111–118.
O"Boskey FJ, Jr. & Panagakos FS (1998) Cytokines stimulate matrix metalloproteinase production by human pulp cells during long-term culture. J Endod 24: 7–10.
O"Connell JP, Willenbrock F, Docherty AJ, Eaton D & Murphy G (1994) Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B. J Biol Chem 269: 14967–73.
O"Farrell TJ & Pourmotabbed T (1998) The fibronectin-like domain is required for the type V and XI collagenolytic activity of gelatinase B. Arch Biochem Biophys 354: 24–30.
Ogata Y, Enghild JJ & Nagase H (1992) Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem 267: 3581–4.
Ohnishi T, Suwa M, Oyama T, Arakaki N, Torii M & Daikuhara Y (2000) Prostaglandin E2 predominantly induces production of hepatocyte growth factor/scatter factor in human dental pulp in acute inflammation. J Dent Res 79: 748–55.
Ohta S, Imai K, Yamashita K, Matsumoto T, Azumano I & Okada Y (1998) Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage. Lab Invest 78: 79–87.
Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M & Okada Y (1997) Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272: 2446–51.
Okada Y, Nagase H & Harris ED, Jr. (1986) A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J Biol Chem 261: 14245–55.
Okada Y, Harris ED, Jr. & Nagase H (1988) The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate. Biochem J 254: 731–41.
Okada Y, Konomi H, Yada T, Kimata K & Nagase H (1989) Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells. FEBS Lett 244: 473–6.
Okada Y & Nakanishi I (1989) Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ("gelatinase") by human neutrophil elastase and cathepsin G. FEBS Lett 249: 353–6.
Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G & Nagase H (1990) Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem 194: 721–30.
Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K & Hayakawa T (1992) Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 267: 21712–9.
Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, Sato H & Seiki M (1995) Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest 72: 311–22.
Olson MW, Bernardo MM, Pietila M, Gervasi DC, Toth M, Kotra LP, Massova I, Mobashery S & Fridman R (2000) Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin 1. J Biol Chem 275: 2661–8.
Olson TM, Hirohata S, Ye J, Leco K, Seldin MF & Apte SS (1998) Cloning of the human tissue inhibitor of metalloproteinase-4 gene (TIMP4) and localization of the TIMP4 and Timp4 genes to human chromosome 3p25 and mouse chromosome 6, respectively. Genomics 51: 148–51.
Overall CM, Wrana JL & Sodek J (1991) Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem 266: 14064–71.
Overall CM (1995) Repression of tissue inhibitor of matrix metalloproteinase expression by all-trans-retinoic acid in rat bone cell populations: comparison with transforming growth factor-beta 1. J Cell Physiol 164: 17–25.
Panagakos FS, O"Boskey JF, Jr. & Rodriguez E (1996) Regulation of pulp cell matrix metalloproteinase production by cytokines and lipopolysaccharides. J Endod 22: 358–61.
Park HI, Ni J, Gerkema FE, Liu D, Belozerov VE & Sang QX (2000) Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor. J Biol Chem 275: 20540–4.
Patterson BC & Sang QA (1997) Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 272: 28823–5.
Patterson ML, Atkinson SJ, Knauper V & Murphy G (2001) Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain. FEBS Lett 503: 158–62.
Pavlaki M, Cao J, Hymowitz M, Chen WT, Bahou W & Zucker S (2002) A conserved sequence within the propeptide domain of membrane type 1 matrix metalloproteinase is critical for function as an intramolecular chaperone. J Biol Chem 277: 2740–9.
Pei D, Majmudar G & Weiss SJ (1994) Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem 269: 25849–55.
Pei D & Weiss SJ (1995) Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375: 244–7.
Pei D & Weiss SJ (1996) Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 271: 9135–40.
Pei D, Kang T & Qi H (2000) Cysteine array matrix metalloproteinase (CA-MMP)/MMP-23 is a type II transmembrane matrix metalloproteinase regulated by a single cleavage for both secretion and activation. J Biol Chem 275: 33988–97.
Pendas AM, Balbin M, Llano E, Jimenez MG & Lopez-Otin C (1997a) Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13). Genomics 40: 222–33.
Pendas AM, Knäuper V, Puente XS, Llano E, Mattei MG, Apte S, Murphy G & Lopez-Otin C (1997b) Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J Biol Chem 272: 4281–6.
Peters DG, Kassam A, St Jean PL, Yonas H & Ferrell RE (1999) Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke 30: 2612–6.
Puente XS, Pendas AM, Llano E, Velasco G & Lopez-Otin C (1996) Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 56: 944–9.
Qin H, Sun Y & Benveniste EN (1999) The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J Biol Chem 274: 29130–7.
Quantin B, Murphy G & Breathnach R (1989) Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochemistry 28: 5327–34.
Ratnikov BI, Rozanov DV, Postnova TI, Baciu PG, Zhang H, DiScipio RG, Chestukhina GG, Smith JW, Deryugina EI & Strongin AY (2002) An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase. J Biol Chem 277: 7377–85.
Rauschenberger CR, Bailey JC & Cootauco CJ (1997) Detection of human IL-2 in normal and inflamed dental pulps. J Endod 23: 366–70.
Ravanti L, Hakkinen L, Larjava H, Saarialho-Kere U, Foschi M, Han J & Kahari VM (1999) Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem 274: 37292–300.
Reboul P, Pelletier JP, Tardif G, Cloutier JM & Martel-Pelletier J (1996) The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest 97: 2011–9.
Rechardt O, Elomaa O, Vaalamo M, Paakkonen K, Jahkola T, Hook-Nikanne J, Hembry RM, Hakkinen L, Kere J & Saarialho-Kere U (2000) Stromelysin-2 is upregulated during normal wound repair and is induced by cytokines. J Invest Dermatol 115: 778–87.
Reinemer P, Grams F, Huber R, Kleine T, Schnierer S, Piper M, Tschesche H & Bode W (1994) Structural implications for the role of the N terminus in the "superactivation" of collagenases. A crystallographic study. FEBS Lett 338: 227–33.
Rekdal C, Sjottem E & Johansen T (2000) The nuclear factor SPBP contains different functional domains and stimulates the activity of various transcriptional activators. J Biol Chem 275: 40288–300.
Rifas L, Fausto A, Scott MJ, Avioli LV & Welgus HG (1994) Expression of metalloproteinases and tissue inhibitors of metalloproteinases in human osteoblast-like cells: differentiation is associated with repression of metalloproteinase biosynthesis. Endocrinology 134: 213–21.
Rifas L, Halstead LR, Peck WA, Avioli LV & Welgus HG (1989) Human osteoblasts in vitro secrete tissue inhibitor of metalloproteinases and gelatinase but not interstitial collagenase as major cellular products. J Clin Invest 84: 686–94.
Risbridger GP, Schmitt JF & Robertson DM (2001) Activins and inhibins in endocrine and other tumors. Endocr Rev 22: 836–58.
Risse G, Jooss K, Neuberg M, Bruller HJ & Muller R (1989) Asymmetrical recognition of the palindromic AP1 binding site (TRE) by Fos protein complexes. Embo J 8: 3825–32.
Risteli J, Niemi S, Trivedi P, Maentausta O, Mowat AP & Risteli L (1988) Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 34: 715–8.
Roberts-Clark DJ & Smith AJ (2000) Angiogenic growth factors in human dentin matrix. Arch Oral Biol 45: 1013–6.
Rozanov DV, Deryugina EI, Ratnikov BI, Monosov EZ, Marchenko GN, Quigley JP & Strongin AY (2001) Mutation analysis of membrane type-1 matrix metalloproteinase (MT1- MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells. J Biol Chem 276: 25705–14.
Ryu OH, Fincham AG, Hu CC, Zhang C, Qian Q, Bartlett JD & Simmer JP (1999) Characterization of recombinant pig enamelysin activity and cleavage of recombinant pig and mouse amelogenins. J Dent Res 78: 743–50.
Sahlberg C, Reponen P, Tryggvason K & Thesleff I (1992) Association between the expression of murine 72 kDa type IV collagenase by odontoblasts and basement membrane degradation during mouse tooth development. Arch Oral Biol 37: 1021–30.
Salo T, Turpeenniemi-Hujanen T & Tryggvason K (1985) Tumor-promoting phorbol esters and cell proliferation stimulate secretion of basement membrane (type IV) collagen-degrading metalloproteinase by human fibroblasts. J Biol Chem 260: 8526–31.
Salo T, Lyons JG, Rahemtulla F, Birkedal-Hansen H & Larjava H (1991) Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J Biol Chem 266: 11436–41.
Sang QA & Douglas DA (1996) Computational sequence analysis of matrix metalloproteinases. J Protein Chem 15: 137–60.
Sang QX, Birkedal-Hansen H & Van Wart HE (1995) Proteolytic and non-proteolytic activation of human neutrophil progelatinase B. Biochim Biophys Acta 1251: 99–108.
Sanz L, Berra E, Municio MM, Dominguez I, Lozano J, Johansen T, Moscat J & Diaz-Meco MT (1994) Zeta PKC plays a critical role during stromelysin promoter activation by platelet-derived growth factor through a novel palindromic element. J Biol Chem 269: 10044–9.
Sasaki T, Gohring W, Mann K, Maurer P, Hohenester E, Knauper V, Murphy G & Timpl R (1997) Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J Biol Chem 272: 9237–43.
Sato H, Kita M & Seiki M (1993) v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J Biol Chem 268: 23460–8.
Sato H & Seiki M (1993) Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8: 395–405.
Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E & Seiki M (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61–5.
Sato H, Kinoshita T, Takino T, Nakayama K & Seiki M (1996) Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 393: 101–4.
Sato T, del Carmen Ovejero M, Hou P, Heegaard AM, Kumegawa M, Foged NT & Delaisse JM (1997) Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. J Cell Sci 110: 589–96.
Saus J, Quinones S, Otani Y, Nagase H, Harris ED, Jr. & Kurkinen M (1988) The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin. J Biol Chem 263: 6742–5.
Schmid TM, Mayne R, Jeffrey JJ & Linsenmayer TF (1986) Type X collagen contains two cleavage sites for a vertebrate collagenase. J Biol Chem 261: 4184–9.
Sedlacek R, Mauch S, Kolb B, Schatzlein C, Eibel H, Peter HH, Schmitt J & Krawinkel U (1998) Matrix metalloproteinase MMP-19 (RASI-1) is expressed on the surface of activated peripheral blood mononuclear cells and is detected as an autoantigen in rheumatoid arthritis. Immunobiology 198: 408–23.
Seltzer JL, Eisen AZ, Bauer EA, Morris NP, Glanville RW & Burgeson RE (1989) Cleavage of type VII collagen by interstitial collagenase and type IV collagenase (gelatinase) derived from human skin. J Biol Chem 264: 3822–6.
Shamamian P, Schwartz JD, Pocock BJ, Monea S, Whiting D, Marcus SG & Mignatti P (2001) Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol 189: 197–206.
Shi S, Robey PG & Gronthos S (2001) Comparison of human dental pulp and bone marrow stromal stem cells by cDNA microarray analysis. Bone 29: 532–9.
Shibata Y, Abiko Y, Moriya Y, Yoshida W & Takiguchi H (1993) Effects of transforming growth factor-beta on collagen gene expression and collagen synthesis level in mineralizing cultures of osteoblast- like cell line, MC3T3-E1. Int J Biochem 25: 239–45.
Shimada T, Nakamura H, Ohuchi E, Fujii Y, Murakami Y, Sato H, Seiki M & Okada Y (1999) Characterization of a truncated recombinant form of human membrane type 3 matrix metalloproteinase. Eur J Biochem 262: 907–14.
Shin SJ, Lee JI, Baek SH & Lim SS (2002) Tissue levels of matrix metalloproteinases in pulps and periapical lesions. J Endod 28: 313–5.
Shipley JM, Doyle GA, Fliszar CJ, Ye QZ, Johnson LL, Shapiro SD, Welgus HG & Senior RM (1996) The structural basis for the elastolytic activity of the 92-kDa and 72- kDa gelatinases. Role of the fibronectin type II-like repeats. J Biol Chem 271: 4335–41.
Shirakawa M, Shiba H, Nakanishi K, Ogawa T, Okamoto H, Nakashima K, Noshiro M & Kato Y (1994) Transforming growth factor-beta-1 reduces alkaline phosphatase mRNA and activity and stimulates cell proliferation in cultures of human pulp cells. J Dent Res 73: 1509–14.
Shlopov BV, Smith GN, Jr., Cole AA & Hasty KA (1999) Differential patterns of response to doxycycline and transforming growth factor beta1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytes. Arthritis Rheum 42: 719–27.
Shuttleworth CA, Ward JL & Hirschmann PN (1978) The presence of type III collagen in the developing tooth. Biochim Biophys Acta 535: 348–55.
Siri A, Knauper V, Veirana N, Caocci F, Murphy G & Zardi L (1995) Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem 270: 8650–4.
Sirum KL & Brinckerhoff CE (1989) Cloning of the genes for human stromelysin and stromelysin 2: differential expression in rheumatoid synovial fibroblasts. Biochemistry 28: 8691–8.
Sloan AJ & Smith AJ (1999) Stimulation of the dentin-pulp complex of rat incisor teeth by transforming growth factor-beta isoforms 1-3 in vitro. Arch Oral Biol 44: 149–56.
Smith AJ & Smith G (1984) Proteolytic activity of rabbit incisor dentin. Arch Oral Biol 29: 1049–50.
Smith AJ, Cassidy N, Perry H, Begue-Kirn C, Ruch JV & Lesot H (1995) Reactionary dentinogenesis. Int J Dev Biol 39: 273–80.
Smith AJ & Lesot H (2001) Induction and regulation of crown dentinogenesis: embryonic events as a template for dental tissue repair? Crit Rev Oral Biol Med 12: 425–37.
Sodek J & Mandell SM (1982) Collagen metabolism in rat incisor predentin in vivo: synthesis and maturation of type I, alpha 1 (I) trimer, and type V collagens. Biochemistry 21: 2011–5.
Song JJ, Celeste AJ, Kong FM, Jirtle RL, Rosen V & Thies RS (1995) Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology 136: 4293–7.
Sorsa T, Ding YL, Ingman T, Salo T, Westerlund U, Haapasalo M, Tschesche H & Konttinen YT (1995) Cellular source, activation and inhibition of dental plaque collagenase. J Clin Periodontol 22: 709–17.
Sorsa T, Salo T, Koivunen E, Tyynela J, Konttinen YT, Bergmann U, Tuuttila A, Niemi E, Teronen O, Heikkila P, Tschesche H, Leinonen J, Osman S & Stenman UH (1997) Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem 272: 21067–74.
Sottrup-Jensen L (1989) Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. J Biol Chem 264: 11539–42.
Sottrup-Jensen L & Birkedal-Hansen H (1989) Human fibroblast collagenase-alpha-macroglobulin interactions. Localization of cleavage sites in the bait regions of five mammalian alpha-macroglobulins. J Biol Chem 264: 393–401.
Sottrup-Jensen L, Sand O, Kristensen L & Fey GH (1989) The alpha-macroglobulin bait region. Sequence diversity and localization of cleavage sites for proteinases in five mammalian alpha- macroglobulins. J Biol Chem 264: 15781–9.
Springman EB, Angleton EL, Birkedal-Hansen H & Van Wart HE (1990) Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. Proc Natl Acad Sci U S A 87: 364–8.
Stahle-Backdahl M, Sandstedt B, Bruce K, Lindahl A, Jimenez MG, Vega JA & Lopez-Otin C (1997) Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab Invest 76: 717–28.
Stanislawski L, Carreau JP, Pouchelet M, Chen ZH & Goldberg M (1997) In vitro culture of human dental pulp cells: some aspects of cells emerging early from the explant. Clin Oral Investig 1: 131–40.
Sternlicht MD & Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463–516.
Stetler-Stevenson WG & Veis A (1986) Type I collagen shows a specific binding affinity for bovine dentin phosphophoryn. Calcif Tissue Int 38: 135–41.
Stetler-Stevenson WG, Krutzsch HC & Liotta LA (1989a) Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264: 17374–8.
Stetler-Stevenson WG, Krutzsch HC, Wacher MP, Margulies IM & Liotta LA (1989b) The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. J Biol Chem 264: 1353–6.
van Strijp AJ, van Steenbergen TJ & ten Cate JM (1997) Bacterial colonization of mineralized and completely demineralized dentin in situ. Caries Res 31: 349–55.
Stöcker W, Grams F, Baumann U, Reinemer P, Gomis-Ruth FX, McKay DB & Bode W (1995) The metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci 4: 823–40.
Stolow MA, Bauzon DD, Li J, Sedgwick T, Liang VC, Sang QA & Shi YB (1996) Identification and characterization of a novel collagenase in Xenopus laevis: possible roles during frog development. Mol Biol Cell 7: 1471–83.
Storm EE, Huynh TV, Copeland NG, Jenkins NA, Kingsley DM & Lee SJ (1994) Limb alterations in brachypodism mice due to mutations in a new member of the TGF beta-superfamily. Nature 368: 639–43.
Stracke JO, Fosang AJ, Last K, Mercuri FA, Pendas AM, Llano E, Perris R, Di Cesare PE, Murphy G & Knäuper V (2000a) Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP). FEBS Lett 478: 52–6.
Stracke JO, Hutton M, Stewart M, Pendas AM, Smith B, Lopez-Otin C, Murphy G & Knäuper V (2000b) Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme. J Biol Chem 275: 14809–16.
Stratmann B, Farr M & Tschesche H (2001) Characterization of C-terminally truncated human tissue inhibitor of metalloproteinases-4 expressed in Pichia pastoris. Biol Chem 382: 987–91.
Stricklin GP, Jeffrey JJ, Roswit WT & Eisen AZ (1983) Human skin fibroblast procollagenase: mechanisms of activation by organomercurials and trypsin. Biochemistry 22: 61–8.
Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA & Goldberg GI (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270: 5331–8.
Su S, Dehnade F & Zafarullah M (1996) Regulation of tissue inhibitor of metalloproteinases-3 gene expression by transforming growth factor-beta and dexamethasone in bovine and human articular chondrocytes. DNA Cell Biol 15: 1039–48.
Subramaniam M, Oursler MJ, Rasmussen K, Riggs BL & Spelsberg TC (1995) TGF-beta regulation of nuclear proto-oncogenes and TGF-beta gene expression in normal human osteoblast-like cells. J Cell Biochem 57: 52–61.
Sulkala M, Wahlgren J, Larmas M, Sorsa T, Teronen O, Salo T & Tjäderhane L (2001) The effects of MMP inhibitors on human salivary MMP activity and caries progression in rats. J Dent Res 80: 1545–49.
Sulkala M, Larmas M, Sorsa T, Salo T & Tjäderhane L (2002) The localization of matrix metalloproteinase-20 (MMP-20, enamelysin) in mature human teeth. J Dent Res 81: 603–7.
Suzuki K, Enghild JJ, Morodomi T, Salvesen G & Nagase H (1990) Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29: 10261–70.
Taipale J, Koli K & Keski-Oja J (1992) Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J Biol Chem 267: 25378–84.
Taipale J, Miyazono K, Heldin CH & Keski-Oja J (1994) Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein. J Cell Biol 124: 171–81.
Takagi Y, Fujisawa R & Sasaki S (1986) Identification of dentin phosphophoryn localization by histochemical stainings. Connect Tissue Res 14: 279–92.
Takata T, Zhao M, Uchida T, Wang T, Aoki T, Bartlett JD & Nikai H (2000) Immunohistochemical detection and distribution of enamelysin (MMP-20) in human odontogenic tumors. J Dent Res 79: 1608–13.
Takeda K, Oida S, Goseki M, Iimura T, Maruoka Y, Amagasa T & Sasaki S (1994) Expression of bone morphogenetic protein genes in the human dental pulp cells. Bone 15: 467–70.
Takiguchi T, Kobayashi M, Suzuki R, Yamaguchi A, Isatsu K, Nishihara T, Nagumo M & Hasegawa K (1998) Recombinant human bone morphogenetic protein-2 stimulates osteoblast differentiation and suppresses matrix metalloproteinase-1 production in human bone cells isolated from mandibulae. J Periodontal Res 33: 476–85.
Takino T, Sato H, Shinagawa A & Seiki M (1995) Identification of the second membrane-type matrix metalloproteinase (MT- MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J Biol Chem 270: 23013–20.
Tamura M, Nagaoka S & Kawagoe M (1996) Interleukin-1 alpha stimulates interstitial collagenase gene expression in human dental pulp fibroblast. J Endod 22: 240–3.
Tardif G, Pelletier JP, Dupuis M, Hambor JE & Martel-Pelletier J (1997) Cloning, sequencing and characterization of the 5"-flanking region of the human collagenase-3 gene. Biochem J 323: 13–6.
Tardif G, Reboul P, Dupuis M, Geng C, Duval N, Pelletier JP & Martel-Pelletier J (2001) Transforming growth factor-beta induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by Smad proteins: cooperation between activator protein-1 and PEA-3 binding sites. J Rheumatol 28: 1631–9.
Tasanen K, Hamalainen ER, Palatsi R & Oikarinen A (1996) Quantification of Pro alpha 1(I) collagen mRNA in skin biopsy specimens: levels of transcription in normal skin and in granuloma annulare. J Invest Dermatol 107: 314–7.
Thiry-Blaise LM, Taquet AN, Reginster JY, Nusgens B, Franchimont P & Lapiere CM (1995) Investigation of the relationship between osteoporosis and the collagenase gene by means of polymorphism of the 5"upstream region of this gene. Calcif Tissue Int 56: 88–91.
Thompson CC, Clegg PD & Carter SD (2001) Differential regulation of gelatinases by transforming growth factor beta-1 in normal equine chondrocytes. Osteoarthritis Cartilage 9: 325–31.
Tjäderhane L, Larjava H, Sorsa T, Uitto VJ, Larmas M & Salo T (1998a) The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions. J Dent Res 77: 1622–9.
Tjäderhane L, Salo T, Larjava H, Larmas M & Overall CM (1998b) A novel organ culture method to study the function of human odontoblasts in vitro: gelatinase expression by odontoblasts is differentially regulated by TGF-β 1. J Dent Res 77: 1486–96.
Tonetti MS, Freiburghaus K, Lang NP & Bickel M (1993) Detection of interleukin-8 and matrix metalloproteinases transcripts in healthy and diseased gingival biopsies by RNA/PCR. J Periodontal Res 28: 511–3.
Torneck CD (1994) Dentin-pulp complex. In: Ten Cate AR (ed) Oral Histology. Development, Structure and Function. 4th edition. Mosby, St. Louis, pp. 169–217.
Trim JE, Samra SK, Arthur MJ, Wright MC, McAulay M, Beri R & Mann DA (2000) Upstream tissue inhibitor of metalloproteinases-1 (TIMP-1) element-1, a novel and essential regulatory DNA motif in the human TIMP-1 gene promoter, directly interacts with a 30-kDa nuclear protein. J Biol Chem 275: 6657–63.
Tschesche H, Knauper V, Kramer S, Michaelis J, Oberhoff R & Reinke H (1992) Latent collagenase and gelatinase from human neutrophils and their activation. Matrix Suppl 1: 245–55.
Tziafas D, Alvanou A, Panagiotakopoulos N, Smith AJ, Lesot H, Komnenou A & Ruch JV (1995) Induction of odontoblast-like cell differentiation in dog dental pulps after in vivo implantation of dentin matrix components. Arch Oral Biol 40: 883–93.
Tziafas D, Smith AJ & Lesot H (2000) Designing new treatment strategies in vital pulp therapy. J Dent 28: 77–92.
Ugwu F, Van Hoef B, Bini A, Collen D & Lijnen HR (1998) Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3). Biochemistry 37: 7231–6.
Uria JA, Jimenez MG, Balbin M, Freije JM & Lopez-Otin C (1998) Differential effects of transforming growth factor-beta on the expression of collagenase-1 and collagenase-3 in human fibroblasts. J Biol Chem 273: 9769–77.
Uria JA & Lopez-Otin C (2000) Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res 60: 4745–51.
Ushiyama J (1989) Gap junctions between odontoblasts revealed by transjunctional flux of fluorescent tracers. Cell Tissue Res 258: 611–6.
Vaday GG, Schor H, Rahat MA, Lahat N & Lider O (2001) Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes. J Leukoc Biol 69: 613–21.
Varghese S & Canalis E (1997) Regulation of collagenase-3 by bone morphogenetic protein-2 in bone cell cultures. Endocrinology 138: 1035–40.
Velasco G, Pendas AM, Fueyo A, Knauper V, Murphy G & Lopez-Otin C (1999) Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J Biol Chem 274: 4570–6.
Velasco G, Cal S, Merlos-Suarez A, Ferrando AA, Alvarez S, Nakano A, Arribas J & Lopez-Otin C (2000) Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. Cancer Res 60: 877–82.
Väänänen A, Srinivas R, Parikka M, Palosaari H, Bartlett JD, Iwata K, Grenman R, Stenman UH, Sorsa T & Salo T (2001) Expression and regulation of MMP-20 in human tongue carcinoma cells. J Dent Res 80: 1884–9.
Wahlgren J, Salo T, Teronen O, Luoto H, Sorsa T & Tjaderhane L (2002) Matrix metalloproteinase-8 (MMP-8) in pulpal and periapical inflammation and periapical root-canal exudates. Int Endod J 35: 897–904.
Wahlgren J, Maisi P, Sorsa T, Sutinen M, Tervahartiala T, Pirila E, Teronen O, Hietanen J, Tjaderhane L & Salo T (2001) Expression and induction of collagenases (MMP-8 and -13) in plasma cells associated with bone-destructive lesions. J Pathol 194: 217–24.
Waltimo J, Risteli L, Risteli J & Lukinmaa PL (1994) Altered collagen expression in human dentin: increased reactivity of type III and presence of type VI in dentinogenesis imperfecta, as revealed by immunoelectron microscopy. J Histochem Cytochem 42: 1593–601.
Wang L, Almqvist KF, Veys EM & Verbruggen G (2002) Control of extracellular matrix homeostasis of normal cartilage by a TGFbeta autocrine pathway. Validation of flow cytometry as a tool to study chondrocyte metabolism in vitro. Osteoarthritis Cartilage 10: 188–98.
Wang X & Pei D (2001) Shedding of membrane type matrix metalloproteinase 5 by a furin-type convertase: a potential mechanism for down-regulation. J Biol Chem 276: 35953–60.
Wang Y, Johnson AR, Ye QZ & Dyer RD (1999) Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain. J Biol Chem 274: 33043–9.
Wang Z, Juttermann R & Soloway PD (2000) TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem 275: 26411–5.
Van Wart HE & Birkedal-Hansen H (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A 87: 5578–82.
Wasylyk C, Gutman A, Nicholson R & Wasylyk B (1991) The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. Embo J 10: 1127–34.
Weinstock M & Leblond CP (1973) Radioautographic visualization of the deposition of a phosphoprotein at the mineralization front in the dentin of the rat incisor. J Cell Biol 56: 838–45.
Weiss SJ, Peppin G, Ortiz X, Ragsdale C & Test ST (1985) Oxidative autoactivation of latent collagenase by human neutrophils. Science 227: 747–9.
Welgus HG, Fliszar CJ, Seltzer JL, Schmid TM & Jeffrey JJ (1990) Differential susceptibility of type X collagen to cleavage by two mammalian interstitial collagenases and 72-kDa type IV collagenase. J Biol Chem 265: 13521–7.
Wernicke D, Seyfert C, Hinzmann B & Gromnica-Ihle E (1996) Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. J Rheumatol 23: 590–5.
Westhoff CS, Freudiger D, Petrow P, Seyfert C, Zacher J, Kriegsmann J, Pap T, Gay S, Stiehl P, Gromnica-Ihle E & Wernicke D (1999) Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis. Arthritis Rheum 42: 1517–27.
White LA, Maute C & Brinckerhoff CE (1997) ETS sites in the promoters of the matrix metalloproteinases collagenase (MMP-1) and stromelysin (MMP-3) are auxiliary elements that regulate basal and phorbol-induced transcription. Connect Tissue Res 36: 321–35.
White LA, Mitchell TI & Brinckerhoff CE (2000) Transforming growth factor beta inhibitory element in the rabbit matrix metalloproteinase-1 (collagenase-1) gene functions as a repressor of constitutive transcription. Biochim Biophys Acta 1490: 259–68.
Wick M, Haronen R, Mumberg D, Burger C, Olsen BR, Budarf ML, Apte SS & Muller R (1995) Structure of the human TIMP-3 gene and its cell cycle-regulated promoter. Biochem J 311: 549–54.
Wilde CG, Hawkins PR, Coleman RT, Levine WB, Delegeane AM, Okamoto PM, Ito LY, Scott RW & Seilhamer JJ (1994) Cloning and characterization of human tissue inhibitor of metalloproteinases-3. DNA Cell Biol 13: 711–8.
Wilhelm SM, Javed T & Miller RL (1984) Human gingival fibroblast collagenase: purification and properties of precursor and active forms. Coll Relat Res 4: 129–52.
Wilhelm SM, Eisen AZ, Teter M, Clark SD, Kronberger A & Goldberg G (1986) Human fibroblast collagenase: glycosylation and tissue-specific levels of enzyme synthesis. Proc Natl Acad Sci U S A 83: 3756–60.
Wilhelm SM, Collier IE, Kronberger A, Eisen AZ, Marmer BL, Grant GA, Bauer EA & Goldberg GI (1987) Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sci U S A 84: 6725–9.
Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA & Goldberg GI (1989) SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264: 17213–21.
Will H & Hinzmann B (1995) cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 231: 602–8.
Windsor LJ, Grenett H, Birkedal-Hansen B, Bodden MK, Engler JA & Birkedal-Hansen H (1993) Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters. J Biol Chem 268: 17341–7.
Woodnutt DA, Wager-Miller J, O"Neill PC, Bothwell M & Byers MR (2000) Neurotrophin receptors and nerve growth factor are differentially expressed in adjacent nonneuronal cells of normal and injured tooth pulp. Cell Tissue Res 299: 225–36.
Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM & Wang EA (1988) Novel regulators of bone formation: molecular clones and activities. Science 242: 1528–34.
Wrana JL, Sodek J, Ber RL & Bellows CG (1986) The effects of platelet-derived transforming growth factor beta on normal human diploid gingival fibroblasts. Eur J Biochem 159: 69–76.
Wrana JL, Attisano L, Wieser R, Ventura F & Massague J (1994) Mechanism of activation of the TGF-beta receptor. Nature 370: 341–7.
Wu JJ, Lark MW, Chun LE & Eyre DR (1991) Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J Biol Chem 266: 5625–8.
Yana I & Weiss SJ (2000) Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol Biol Cell 11: 2387–401.
Yang M, Murray MT & Kurkinen M (1997) A novel matrix metalloproteinase gene (XMMP) encoding vitronectin-like motifs is transiently expressed in Xenopus laevis early embryo development. J Biol Chem 272: 13527–33.
Yang M & Kurkinen M (1998) Cloning and characterization of a novel matrix metalloproteinase (MMP), CMMP, from chicken embryo fibroblasts. CMMP, Xenopus XMMP, and human MMP19 have a conserved unique cysteine in the catalytic domain. J Biol Chem 273: 17893–900.
Yoshiba N, Yoshiba K, Iwaku M & Ozawa H (1996) Immunolocalization of the small proteoglycan decorin in human teeth. Arch Oral Biol 41: 351–7.
Yu Q & Stamenkovic I (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14: 163–76.
Yu WH & Woessner JF, Jr. (2000) Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). J Biol Chem 275: 4183–91.
Yu WH, Yu S, Meng Q, Brew K & Woessner JF, Jr. (2000) TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem 275: 31226–32.
Yuan W & Varga J (2001) Transforming growth factor-beta repression of matrix metalloproteinase- 1 in dermal fibroblasts involves Smad3. J Biol Chem 276: 38502–10.
Zafarullah M, Su S, Martel-Pelletier J, DiBattista JA, Costello BG, Stetler-Stevenson WG & Pelletier JP (1996) Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA is constitutively expressed in bovine, human normal, and osteoarthritic articular chondrocytes. J Cell Biochem 60: 211–7.
Zhang Y, Feng XH & Derynck R (1998) Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 394: 909–13.
Zhao S, Sloan AJ, Murray PE, Lumley PJ & Smith AJ (2000) Ultrastructural localisation of TGF-beta exposure in dentin by chemical treatment. Histochem J 32: 489–94.
Zucker S, Drews M, Conner C, Foda HD, DeClerck YA, Langley KE, Bahou WF, Docherty AJ & Cao J (1998) Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 273: 1216–22.